1Louis DN,Ohgaki H,Wiestler OD,et al. The 2007 WHO classifi cation of tumours of the central nervous system[J]. Acta Neuro pathol,2007,114(2) :97-109. 被引量：1
2Griffin CA, Burger P, Morsberger L, et al. Idemification of der( 1:19) (q10 : p10) in five oligodendrogliomas suggests mechanism of concurrent lp and 19q loss[J]. J Neuropathol Exp Neurol,2006, 65(10) :988-994. 被引量：1
3Jenkins RB,Blair H,Ballman KV,et al. A t(1:1g)(q10:pl0) me- diates the combined deletions of lp and 19q and predicts a better prognosis of patients with oligodendroglioma [J]. Cancer Res, 2006,66(20) : 9852-9861. 被引量：1
4Cairncross G,Jenkins R. Gliomas with 1p/19q codeletion: a. k. a. oligodendroglioma[J1. Cancer J, 2008,14 ( 6), 352-357. 被引量：1
5Aldape K, Burger PC, Perry A. Clinicopathologic aspects of lp/ 19q loss and the diagnosis of oligodendroglioma[J]. Arch Pathol Lab Med,2007,131(2) :242-251. 被引量：1
6Li KK,Pang JC,Chung NY, et al. EMP3 overexpression is associ ated with oligodendroglial tumors retaining chromosome arms lp and 19q[J]. lnt J Cancer,2007,120(4):947-950. 被引量：1
7Kouwenhoven MC,Gorlia T,Kros JM,et al. Molecular analysis of anaplastic oligodendroglial tumors in a prospective randomized study:A report from EORTC study 26951[J]. Neuro Oncol, 2009,11(6) : 737-746. 被引量：1
8Kaloshi G,Benouaicb-Amiel A,Diakite F,et al. Temozolomide for low-grade gliomas: predictive impact of lp/19q loss on response and outcome [J]. Neurology,2007,68(21):1831 1836. 被引量：1
9Snuderl M, Eichler AF, Ligon KL, et al. Polysomy for chromo somesl and 19 predicts earlier recurrence in anaplastic oligoden drogliomaswith concurrent lp/19q loss [J]. Clin Cancer Res, 2009,15(20) :6430-6437. 被引量：1
10Cairncross G, Berkey B, Shaw E, et al. Phase Ⅲ trial of chemo- therapyplus radiotherapy compared with radiotherapy alone for- pure and mixed anaplastie oligodendreglioma: Intergroup Radia- tion Therapy Oncology Group Trial 9402[J]. Ciin Oncol, 2006,24 (18) : 2707-2714. 被引量：1
二级参考文献4
1Bruce JN,Criscuolo GR,M errrili MJ,et al.Vascular permeability induced by protein product of malignant brain tumors:inhibition by dexamethasone[J].J Neuro surg,1987,67:880. 被引量：1
3PM Ganigi,V Santosh,B Anandh,et al.Expression of P53、EGFR、pRd and bcl-2 protens in pediatric Glioblastoma Multiforme:A Study of 54 Patients[J].pediatric Neuosurgery,2005,41:292. 被引量：1
4Kies MS,Arquette ma,Nabell L,et al,Final report of the efficacy and safety of the antiepidermal growth factor antibody Erbitux(IMC2C225),in combination with cisplatin inpatients with recurrent squamous cell carcinoma of the head and neck (SCCHN) refractory to cisplatining chemotherapy[J].proc Am Soc Clin Oncol,2002,21:232. 被引量：1
